ArticleFrontiers in microbiology2021
Toward an Integrated Genome-Based Surveillance of
Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 32 citations in OpenAlex.
- cgDist: Nucleotide-level distance calculation from cgMLST allelic profiles.NAR genomics and bioinformatics · 2026Article
- Lineage-aware comparison of extended-spectrumMicrobial genomics · 2026Article
- Review
- Phylodynamic analysis ofMicrobial genomics · 2026Article
- Integrating serotyping, MLST, and phenotypic data: decoding the evolutionary drivers ofApplied and environmental microbiology · 2025Article
- A Comprehensive Guide to Quality Assessment and Data Submission for Genomic Surveillance of Enteric Pathogens.Methods in molecular biology (Clifton, N.J.) · 2025Article
- Low occurrence and clonal relatedness of multi-drug resistantFrontiers in veterinary science · 2025Article
- Unraveling the impact of genome assembly on bacterial typing: a one health perspective.BMC genomics · 2024Article
- Unveiling the synergistic potency of chlorhexidine and azithromycin in combined action.Naunyn-Schmiedeberg's archives of pharmacology · 2024Article
- Emerging Strategies against Non-TyphoidalCurrent issues in molecular biology · 2024Review
- Whole-Genome Sequencing of Human and PorcineAntibiotics (Basel, Switzerland) · 2024Article
- Rapid Dot-Blot Immunoassay for Detecting MultipleJournal of microbiology and biotechnology · 2024Article
- Genetic Diversity ofPathogens (Basel, Switzerland) · 2024Article
- Review
- Comparison of Phenotype Nutritional Profiles and Phosphate Metabolism Genes in Four Serovars ofMicroorganisms · 2023Article
- Genomic diversity and epidemiological significance of non-typhoidalMicrobial genomics · 2023Article
- Multicenter Preparedness Exercise Enables Rapid Development of Cluster-Specific PCR-Based Screening Assays from Bacterial Genomic Data.Journal of clinical microbiology · 2023Article
- Genetic characterization of a multidrug-resistantFrontiers in microbiology · 2023Article
- Prevention and Control of HumanInternational journal of food science · 2023Review
- Genome-Wide Searching Single Nucleotide-Polymorphisms (SNPs) and SNPs-Targeting a Multiplex Primer for Identification of CommonPathogens (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite extensive monitoring programs and preventative measures,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.